title: Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group.
abstract: The determinants of the degree of metabolic decompensation at the diagnosis of type 1 (insulin dependent) diabetes mellitus (IDDM) and the possible role of diabetic ketoacidosis in the preservation and recovery of residual beta cell function were examined in 745 Finnish children and adolescents. Children younger than 2 years or older than 10 years of age were found to be more susceptible to diabetic ketoacidosis than children between 2 and 10 years of age (< 2 years: 53.3%; 2-10 years: 16.9%; > 10 years: 33.3%). Children from families with poor parental educational level had ketoacidosis more often than those from families with high parental educational level (24.4% v 16.9%). A serum C peptide concentration of 0.10 nmol/l or more was associated with a favourable metabolic situation. Low serum C peptide concentrations, high requirement of exogenous insulin, low prevalence of remission, and high glycated haemoglobin concentrations were observed during the follow up in the group of probands having diabetic ketoacidosis at the diagnosis of IDDM. Thus diabetic ketoacidosis at diagnosis is related to a decreased capacity for beta cell recovery after the clinical manifestation of IDDM in children.
authors.affiliation: Department of Paediatrics, Kuopio University Hospital, Finland.
authors.forename: J
authors.initials: J
authors.lastname: Komulainen
authors.forename: R
authors.initials: R
authors.lastname: Lounamaa
authors.forename: M
authors.initials: M
authors.lastname: Knip
authors.forename: E A
authors.initials: EA
authors.lastname: Kaprio
authors.forename: H K
authors.initials: HK
authors.lastname: Akerblom
mesh_terms: D000293:Adolescent; D000367:Age Factors; D002096:C-Peptide / Q000097:blood; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000503:physiopathology*; D016883:Diabetic Ketoacidosis / Q000097:blood / Q000503:physiopathology*; D004334:Drug Administration Schedule; D004522:Educational Status; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007223:Infant; D007328:Insulin / Q000008:administration & dosage; D007515:Islets of Langerhans / Q000503:physiopathology*; D008297:Male; D010290:Parents; D011379:Prognosis
chemical_list: D002096:C-Peptide; D006442:Glycated Hemoglobin; D007328:Insulin